Long-term clinical outcomes of COVID-19 patients treated with imatinib.

Duijvelaar, Erik; Schippers, Job R; Smeele, Patrick J; de Raaf, Michiel Alexander; Vanhove, Arthur L E M; Blok, Siebe G; Twisk, Jos W R; Vonk Noordegraaf, Anton; de Man, Frances S; Bogaard, Harm Jan; Aman, Jurjan

Duijvelaar, Erik; Schippers, Job R; Smeele, Patrick J; de Raaf, Michiel Alexander; Vanhove, Arthur L E M; Blok, Siebe G; Twisk, Jos W R; Vonk Noordegraaf, Anton; de Man, Frances S; Bogaard, Harm Jan; Aman, Jurjan.

Duijvelaar E; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Schippers JR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Smeele PJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
de Raaf MA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Vanhove ALEM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Blok SG; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Twisk JWR; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Vonk Noordegraaf A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
de Man FS; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Bogaard HJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Aman J; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands. Electronic address: j.aman@amsterdamumc.nl.

Lancet Respir Med ; 10(4): e34-e35, 2022 04.

Article in English | MEDLINE | ID: covidwho-1707115

Subject(s)

Antineoplastic Agents; COVID-19 Drug Treatment; Antineoplastic Agents/therapeutic use; Follow-Up Studies; Humans; Imatinib Mesylate/therapeutic use; Protein Kinase Inhibitors/therapeutic use; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Antineoplastic Agents Type of study: Cohort study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(22)00052-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google